San Diego, CA, United States of America

Bethany K Okada

This inventor holds 1 USPTO granted patent. Top assignee: Princeton University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bethany K Okada. Retrieved from https://idiyas.com/inventor/bethany-k-okada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bethany K Okada: Innovator in Anti-Virulence Research

Introduction

Bethany K Okada is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of medical research, particularly in the area of anti-virulence agents. Her innovative work has the potential to impact the treatment of bacterial infections.

Latest Patents

Bethany K Okada holds 1 patent for her invention titled "Guanfacine as an anti-virulence agent." This patent discloses methods for using guanfacine, an analog or derivative of guanfacine, or a pharmaceutically acceptable salt thereof, to reduce the virulence of a bacterial pathogen. The method generally involves administering a therapeutically effective dose of guanfacine to a patient or contacting the bacterial pathogen directly with the compound.

Career Highlights

Bethany is affiliated with Princeton University, where she conducts her research and develops her innovative ideas. Her work is recognized for its potential to change the landscape of bacterial infection treatment.

Collaborations

Some of her notable coworkers include Mohammad R Seyedsayamdost and Anran Li. Their collaborative efforts contribute to the advancement of research in the field.

Conclusion

Bethany K Okada is a trailblazer in the realm of anti-virulence research, and her contributions are paving the way for new treatment methodologies. Her innovative spirit and dedication to science continue to inspire future advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…